OPEN END-TURBO-OPTIONSSCHEIN - RESMED | Real-time BOERSE MUENCHEN 01:06:12 03/06/2024 pm IST | ||
| 2.37 EUR | +1.72% |
|
| 1 month | -26.03% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RESMED, INC.
Latest news about RESMED, INC.
More news
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 2.37 | +1.72% |
| 31/24/31 | 2.33 | -12.08% |
| 30/24/30 | 2.65 | +12.29% |
| 29/24/29 | 2.36 | -4.84% |
| 28/24/28 | 2.48 | -18.42% |
Real-time BOERSE MUENCHEN
Last update June 03, 2024 at 01:06 pm IST
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RESMED, INC. |
| Issuer | HSBC |
| WKN | HS6982 |
| ISIN | DE000HS69827 |
| Date issued | 26/04/2024 |
| Strike | 182.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.29 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.8 € |
|---|---|
| Lowest since issue | 2.16 € |
| Spread | 0.17 € |
| Spread % | 6.77% |
Company Profile
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Sector
-
Consensus: ResMed, Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
206.3
USD
Average target price
216.6
USD
Spread / Average Target
+5.00%
- Stock Market
- Certificates
- Certificat
